These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19150983)

  • 41. FANCJ at the FORK.
    Cantor SB; Nayak S
    Mutat Res; 2016 Jun; 788():7-11. PubMed ID: 26926912
    [No Abstract]   [Full Text] [Related]  

  • 42. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.
    Cantor SB; Guillemette S
    Future Oncol; 2011 Feb; 7(2):253-61. PubMed ID: 21345144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
    Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
    Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia.
    Brosh RM; Cantor SB
    Front Genet; 2014; 5():372. PubMed ID: 25374583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the link between BACH1 and BRCA1 in the FA pathway.
    Cantor SB; Andreassen PR
    Cell Cycle; 2006 Jan; 5(2):164-7. PubMed ID: 16357529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BLM's balancing act and the involvement of FANCJ in DNA repair.
    Dhar S; Brosh RM
    Cell Cycle; 2018; 17(18):2207-2220. PubMed ID: 30209988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FANCI and FANCD2 have common as well as independent functions during the cellular replication stress response.
    Thompson EL; Yeo JE; Lee EA; Kan Y; Raghunandan M; Wiek C; Hanenberg H; Schärer OD; Hendrickson EA; Sobeck A
    Nucleic Acids Res; 2017 Nov; 45(20):11837-11857. PubMed ID: 29059323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts.
    London TB; Barber LJ; Mosedale G; Kelly GP; Balasubramanian S; Hickson ID; Boulton SJ; Hiom K
    J Biol Chem; 2008 Dec; 283(52):36132-9. PubMed ID: 18978354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of the Fanconi anemia pathway in DNA repair and maintenance of genome stability].
    Koczorowska AM; Białkowska A; Kluzek K; Zdzienicka MZ
    Postepy Hig Med Dosw (Online); 2014 May; 68():459-72. PubMed ID: 24864098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ATP-dependent nucleosome unwrapping catalyzed by human RAD51.
    North JA; Amunugama R; Klajner M; Bruns AN; Poirier MG; Fishel R
    Nucleic Acids Res; 2013 Aug; 41(15):7302-12. PubMed ID: 23757189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p53 suppresses BRCA2-stimulated ATPase and strand exchange functions of human RAD51.
    Verma S; Rao BJ
    J Biochem; 2013 Sep; 154(3):237-48. PubMed ID: 23678008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection.
    Zadorozhny K; Sannino V; Beláň O; Mlčoušková J; Špírek M; Costanzo V; Krejčí L
    Cell Rep; 2017 Oct; 21(2):333-340. PubMed ID: 29020621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homologous recombination in DNA repair and DNA damage tolerance.
    Li X; Heyer WD
    Cell Res; 2008 Jan; 18(1):99-113. PubMed ID: 18166982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
    Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
    J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic stability: FANCJ-dependent G4 DNA repair.
    Maizels N
    Curr Biol; 2008 Jul; 18(14):R613-4. PubMed ID: 18644339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physical interaction of RECQ5 helicase with RAD51 facilitates its anti-recombinase activity.
    Schwendener S; Raynard S; Paliwal S; Cheng A; Kanagaraj R; Shevelev I; Stark JM; Sung P; Janscak P
    J Biol Chem; 2010 May; 285(21):15739-45. PubMed ID: 20348101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical characterization of Warsaw breakage syndrome helicase.
    Wu Y; Sommers JA; Khan I; de Winter JP; Brosh RM
    J Biol Chem; 2012 Jan; 287(2):1007-21. PubMed ID: 22102414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.
    Xie J; Litman R; Wang S; Peng M; Guillemette S; Rooney T; Cantor SB
    Oncogene; 2010 Apr; 29(17):2499-508. PubMed ID: 20173781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. G-quadruplex recognition and remodeling by the FANCJ helicase.
    Wu CG; Spies M
    Nucleic Acids Res; 2016 Oct; 44(18):8742-8753. PubMed ID: 27342280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
    Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
    J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.